Prognostic value of steroid receptors after long-term follow-up of 2257 operable breast cancers

British Journal of Cancer

Volumn 73, Issue 12, 1996, Pages 1545-1551

  Pichon, M F ^a,b   Broet, P ^a   Magdelenat, H ^a   Delarue, J C ^a   Spyratos, F ^a   Basuyau, J P ^a   Saez, S ^a   Rallet, A ^a   Courriere, P ^a   Millon, R ^a   Asselain, B ^a  

^a FNCLCC   (France)

^b CENTRE RENÉ HUGUENIN   (France)

Author keywords

Breast cancer; Prognosis; Steroid receptors

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; STEROID RECEPTOR; TUMOR MARKER;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER STAGING; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RADIOASSAY;

EID: 8944233861     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.291     Document Type: Article

References (22)

1. AALTOMAA S, LIPPONEN P, ESKILINEN M, KOSMA VM, MARIN S, ALHAVA E AND SYRJANEN K. (1991). Hormone receptors as prognostic factors in female breast cancer. Ann. Med., 23, 643-648.
2. ADAMI HO, MALKER B, HOLMBERG L, PERSONN I AND STONE B (1986). The relation between survival and age at diagnosis in breast cancer. N. Engl. J. Med., 315, 559-563.
3. BLOOM HJG AND RICHARDSON WW. (1957). Histological grading and prognosis in breast cancer. A study of 1409 cases of which 359 have been followed 15 years. Br. J. Cancer, 11, 359-377.
4. CHEVALLIER B, HEINZMANN F, MOSSERI V, DAUCE JP, BASTIT P, GRAIC Y, BRUNELLE P, BASUYAU JP, COMOZ M AND ASSELAIN B. (1988). Prognostic value of estrogen and progesterone receptors in operable breast cancer. Cancer, 62, 2517-2524.
5. CLARK GM, WENGER CR, BEARDSLEE S, OWENS MA, POUNDS G, OLDAKER T, VENDRELY P, PANDIAN MR, HARRINGTON D AND MCGUIRE WL. (1993). How to integrate steroid hormone receptor, flow cytometric, and other prognostic information in regard to primary breast cancer. Cancer, 71, 2157-2162.
6. COX DR. (1972). Regression models and life table (with discussion). J. R. Stat. Soc. B, 34, 187-202.
7. ENQUETE PERMANENTE CANCER 1975-1986. (1991). In Monographie des Cancers du Sein. Fédération Nationale des Centres de Lutte contre le Cancer (FNCLCC). pp. 37. Doin: Paris.
8. GELBFISH GA, DAVIDSON AL, KOPEL S, SCHREIBMAN B, GELB-FISH JS, DEGENSHEIN GA, HERZ BL AND CUNNINGHAM JN (1988). Relationship of estrogen and progesterone receptors to prognosis in breast cancer. Ann. Surg., 207, 75-79.
9. HAYBITTLE JL, BLAMEY RW, ELSTON CW, JOHNSON J, DOYLE PJ, CAMPBELL FC, NICHOLSON RI AND GRIFFITHS K. (1982). A prognostic index in primary breast cancer. Br. J. Cancer, 45, 361-366.
10. HOST H AND LUND E. (1986). Age as a prognostic factor in breast cancer. Cancer, 57, 2217-2221.
11. JACQUEMIER J, VAGUE D, LIEUTAUD R, DE MASCAREL I, TROJANI M, MEUGE C, LE DOUSSAL V, GENTILE A, HEBERT H, KEMENY F, AMOUROUX J AND CONTESSO G. (1981). Définition et reproductibilité du grading de Scarff et Bloom. In Evaluation des Moyens de Diagnostic du Cancer du Sein, Gest J. (ed.) pp. 173-185. JMT Conseil: Paris.
12. KALBFLEISH JD AND PRENTICE RL. (1980). The statistical analysis of failure time data. pp. 122-127. John Wiley and Sons: New York.
13. KAPLAN EL AND MEIER P. (1958). Non-parametric estimation for incomplete observation. J. Am. Stat. Assoc., 53, 457-471.
14. MARTIN PM, BRESSOT N, DELARUE JC, MAGDELENAT H, PICHON MF, SAEZ S AND SPYRATOS F. (1981). Protocole coopératif intercentres. Dosage des récépteurs hormonaux stéroidiens intratissulaires en pathologie mammaire humaine. In Evaluation des Moyens de Diagnostic du Cancer du Sein, Gest J. (ed.) pp. 173-185. JMT Conseil: Paris.
15. MATHIESEN O, BONDERUP O, CARL J, PANDURO J AND PEDERSEN KO. (1991). The prognostic value of estrogen and progesterone receptors in female breast cancer. Acta Oncol., 30, 691-695.
16. PETO R AND PETO J. (1972). Asymptotically efficient rank invariant test procedures (with discussion). J.R. Stat. Soc. A, 135, 185-207.
17. RAEMAEKERS JMM, BEEX LVAM, KOENDERS AJM, PIETERS GFFM, SMALS AGH, BENRAAD TJ, KLOPPENBORG PWC AND THE BREAST CANCER GROUP. (1985). Disease-free interval and estrogen receptor activity in tumor tissue of patients with primary breast cancer: analysis after long-term follow-up. Breast Cancer Res. Treat., 6, 123-130.
18. SILVESTRINI R, DAIDONE MG, LUISI A, BORACCHI P, MEZZETI M, DI FRONZO G, ANDREOLA S, SALVADORI B AND VERONESI U. (1995). Biologic and clinicopathologic factors as indicators of specific relapse types in node-negative breast cancer. J. Clin. Oncol., 13, 697-704.
19. SPYRATOS F, HACENE K, TUBIANA-HULIN M, PALLUD C AND BRUNET M. (1989). Prognostic value of estrogen and progesterone receptors in primary infiltrating ductal breast cancer. Eur J. Cancer Clin. Oncol., 25, 1233-1240.
20. STAL O, CARSTENSEN J, HATSCHEK T AND NORDENKJOLD B. (1992). Significance of S-phase fraction and hormone receptor content in the management of young breast cancer patients. Br. J. Cancer, 66, 706-711.
21. THORPE SM, ROSE C, RASMUSSEN BB, MOURIDSEN HT, BAYER T AND KEIDING N. (1987). Prognostic value of steroid hormone receptors: multivariate analysis of systematically untreated patients with node negative primary breast cancer. Cancer Res., 47, 6126-6133.
22. TODD JH, DOWLE C, WILLIAMS MR, ELSTON CW, ELLIS IO, HINTON CP, BLAMEY RW AND HAYBITTLE JL (1987). Confirmation of a prognostic index in primary breast cancer. Br. J. Cancer, 56, 489-492.